Effexor, Lipitor reverse-payment class actions reinstated
A US appeals court reinstated two major antitrust class actions Monday, one that alleged Pfizer and Ranbaxy violated the antitrust laws by delaying generic entry of cholesterol drug Lipitor and a...To view the full article, register now.
Already a subscriber? Click here to view full article